Compare ZUMZ & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZUMZ | OSUR |
|---|---|---|
| Founded | 1978 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 304.2M | 247.6M |
| IPO Year | 2005 | 2000 |
| Metric | ZUMZ | OSUR |
|---|---|---|
| Price | $13.28 | $3.52 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $18.00 | $3.00 |
| AVG Volume (30 Days) | 293.4K | ★ 433.7K |
| Earning Date | 06-04-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 966.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $929,057,000.00 | $167,064,000.00 |
| Revenue This Year | $4.30 | $4.48 |
| Revenue Next Year | $3.30 | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 4.48 | N/A |
| 52 Week Low | $13.24 | $2.08 |
| 52 Week High | $31.70 | $4.58 |
| Indicator | ZUMZ | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 20.33 | 44.25 |
| Support Level | N/A | $2.86 |
| Resistance Level | $18.87 | $4.29 |
| Average True Range (ATR) | 0.66 | 0.12 |
| MACD | -0.45 | 0.02 |
| Stochastic Oscillator | 0.64 | 66.36 |
Zumiez Inc is a United States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art, action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.